Literature DB >> 12393091

The role of locally expressed angiotensin converting enzyme in cardiac remodeling after myocardial infarction in mice.

Wendy M Aartsen1, Martin P Schuijt, A H Jan Danser, Mat J A P Daemen, Jos F M Smits.   

Abstract

OBJECTIVE: Angiotensin II, generated from angiotensin I by angiotensin converting enzyme (ACE), induces multiple effects including vasoconstriction, positive cardiac inotropy, hypertrophy of cardiomyocytes and proliferation of fibroblasts. ACE exists both in a tissue-bound (t-ACE) and a soluble form. The functional importance of locally produced angiotensin II is still unclear. In the present study, mice lacking tissue-bound angiotensin converting enzyme (t-ACE -/-) were used to investigate the importance of t-ACE during cardiac remodeling after myocardial infarction.
METHODS: Mice were subjected to coronary artery occlusion or sham surgery. At 14 days after MI, stroke volume (SV) was determined with an electromagnetic flow probe around the ascending aorta. Mean arterial pressure (MAP) was measured through a cannula in the abdominal aorta. Both parameters were determined at rest and after a volume loading of 2.5 ml warm (37 degrees C) Ringer's solution in 60 s. Hearts were dissected and formalin-fixed to measure infarct size, cardiac dimensions and collagen concentration. Tissue levels of angiotensin I and II were determined in hearts and kidneys.
RESULTS: At rest, under pentobarbital anaesthesia, t-ACE -/- mice (n=12) exhibited a significantly lower MAP (26+/-3 vs. 45+/-3 mmHg) than t-ACE +/+ (n=11). SV was similar in both strains. Maximal SV was significantly reduced after MI. Furthermore, infarcted t-ACE -/- (n=6) exhibited a significantly lower maximal SV compared to infarcted t-ACE +/+ mice (n=5; 20.4+/-1.5 vs. 29.6+/-2.3 microl). Structural cardiac parameters as well as cardiac and renal angiotensin II levels in t-ACE -/- and t-ACE +/+ were comparable.
CONCLUSIONS: These results suggest that the structural adaptations of the heart that follow MI are independent of t-ACE. However, the presence of t-ACE is necessary for maintenance of cardiac function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393091     DOI: 10.1016/s0008-6363(02)00516-3

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  5 in total

1.  Myocardial and Serum Galectin-3 Expression Dynamics Marks Post-Myocardial Infarction Cardiac Remodelling.

Authors:  Umesh C Sharma; Wassim Mosleh; Milind R Chaudhari; Rujuta Katkar; Brian Weil; Chris Evelo; Thomas R Cimato; Saraswati Pokharel; W Matthijs Blankesteijn; Gen Suzuki
Journal:  Heart Lung Circ       Date:  2016-12-19       Impact factor: 2.975

2.  Tagged cine magnetic resonance imaging to quantify regional mechanical changes after acute myocardial infarction.

Authors:  Badri Karthikeyan; Swati D Sonkawade; Saraswati Pokharel; Marilena Preda; Ferdinand Schweser; Robert Zivadinov; Minhyung Kim; Umesh C Sharma
Journal:  Magn Reson Imaging       Date:  2019-10-24       Impact factor: 2.546

3.  Ophiopogonin B induces gastric cancer cell death by blocking the GPX4/xCT-dependent ferroptosis pathway.

Authors:  Liyi Zhang; Chunlei Li; Yuzhan Zhang; Jinwen Zhang; Xiaolei Yang
Journal:  Oncol Lett       Date:  2022-02-01       Impact factor: 2.967

4.  Opposite effects of uracil and adenine nucleotides on the survival of murine cardiomyocytes.

Authors:  Alessia Mazzola; Emanuela Amoruso; Elena Beltrami; Davide Lecca; Silvia Ferrario; Simona Cosentino; Elena Tremoli; Stefania Ceruti; Maria P Abbracchio
Journal:  J Cell Mol Med       Date:  2008-04       Impact factor: 5.310

5.  The Therapeutic Potential of Blocking Galectin-3 Expression in Acute Myocardial Infarction and Mitigating Inflammation of Infarct Region: A Clinical Outcome-Based Translational Study.

Authors:  Wassim Mosleh; Milind R Chaudhari; Swati Sonkawade; Supriya Mahajan; Charl Khalil; Kevin Frodey; Tanvi Shah; Suraj Dahal; Roshan Karki; Rujuta Katkar; W Matthijs Blankesteijn; Brian Page; Saraswati Pokharel; Minhyung Kim; Umesh C Sharma
Journal:  Biomark Insights       Date:  2018-05-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.